Swedish Orphan Biovitrum AB (SWOBY)
24.31
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Swedish Orphan Biovitrum Net Income (Quarterly) : 117.25M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 117.25M |
| March 31, 2026 | 144.19M |
| December 31, 2025 | 197.94M |
| September 30, 2025 | -304.17M |
| June 30, 2025 | 65.63M |
| March 31, 2025 | 81.98M |
| December 31, 2024 | 129.03M |
| September 30, 2024 | 140.47M |
| June 30, 2024 | 20.95M |
| March 31, 2024 | 76.96M |
| December 31, 2023 | 96.18M |
| September 30, 2023 | 8.694M |
| June 30, 2023 | 21.06M |
| March 31, 2023 | 102.21M |
| December 31, 2022 | 129.23M |
| September 30, 2022 | 42.75M |
| June 30, 2022 | 26.20M |
| March 31, 2022 | 58.13M |
| December 31, 2021 | 140.03M |
| September 30, 2021 | 54.70M |
| June 30, 2021 | 31.86M |
| March 31, 2021 | 82.83M |
| December 31, 2020 | 174.41M |
| September 30, 2020 | 31.35M |
| June 30, 2020 | 29.24M |
| Date | Value |
|---|---|
| March 31, 2020 | 122.08M |
| December 31, 2019 | 141.41M |
| September 30, 2019 | 56.52M |
| June 30, 2019 | 52.81M |
| March 31, 2019 | 98.41M |
| December 31, 2018 | 65.78M |
| September 30, 2018 | 69.64M |
| June 30, 2018 | 78.91M |
| March 31, 2018 | 63.48M |
| December 31, 2017 | 42.91M |
| September 30, 2017 | 40.16M |
| June 30, 2017 | 30.11M |
| March 31, 2017 | 22.64M |
| December 31, 2016 | 8.069M |
| September 30, 2016 | 15.77M |
| June 30, 2016 | 37.45M |
| March 31, 2016 | 35.76M |
| December 31, 2015 | -1.059M |
| September 30, 2015 | 0.5892M |
| June 30, 2015 | 1.070M |
| March 31, 2015 | 12.71M |
| December 31, 2014 | -2.342M |
| September 30, 2014 | 7.586M |
| June 30, 2014 | 3.877M |
| March 31, 2014 | -50.86M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Hansa Biopharma AB | -27.82M |
| BioArctic AB | 23.24M |
| Diamyd Medical AB | -13.67M |
| BONESUPPORT HOLDING AB | 8.743M |
| BioInvent International AB | -13.04M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 837.43M |
| Total Expenses (Quarterly) | 720.28M |
| EPS Diluted (Quarterly) | 0.1673 |
| Enterprise Value | 18.59B |
| Gross Profit Margin (Quarterly) | 61.17% |
| Profit Margin (Quarterly) | 14.00% |
| Earnings Yield | 0.89% |
| Operating Earnings Yield | 5.81% |
| Normalized Earnings Yield | 4.096 |